| Literature DB >> 33921724 |
Tapan Behl1, Gabriele Rocchetti2, Swati Chadha1, Gokhan Zengin3, Simona Bungau4, Arun Kumar1, Vineet Mehta5, Md Sahab Uddin6,7, Gaurav Khullar1, Dhruv Setia1, Sandeep Arora1, Kouadio Ibrahime Sinan3, Gunes Ak3, Predrag Putnik8, Monica Gallo9, Domenico Montesano10.
Abstract
To date, the leading causes of mortality and morbidity worldwide include viral infections, such as Ebola, influenza virus, acquired immunodeficiency syndrome (AIDS), severe acute respiratory syndrome (SARS) and recently COVID-19 disease, caused by the SARS-CoV-2 virus. Currently, we can count on a narrow range of antiviral drugs, especially older generation ones like ribavirin and interferon which are effective against viruses in vitro but can often be ineffective in patients. In addition to these, we have antiviral agents for the treatment of herpes virus, influenza virus, HIV and hepatitis virus. Recently, drugs used in the past especially against ebolavirus, such as remdesivir and favipiravir, have been considered for the treatment of COVID-19 disease. However, even if these drugs represent important tools against viral diseases, they are certainly not sufficient to defend us from the multitude of viruses present in the environment. This represents a huge problem, especially considering the unprecedented global threat due to the advancement of COVID-19, which represents a potential risk to the health and life of millions of people. The demand, therefore, for new and effective antiviral drugs is very high. This review focuses on three fundamental points: (1) presents the main threats to human health, reviewing the most widespread viral diseases in the world, thus describing the scenario caused by the disease in question each time and evaluating the specific therapeutic remedies currently available. (2) It comprehensively describes main phytochemical classes, in particular from plant foods, with proven antiviral activities, the viruses potentially treated with the described phytochemicals. (3) Consideration of the various applications of drug delivery systems in order to improve the bioavailability of these compounds or extracts. A PRISMA flow diagram was used for the inclusion of the works. Taking into consideration the recent dramatic events caused by COVID-19 pandemic, the cry of alarm that denounces critical need for new antiviral drugs is extremely strong. For these reasons, a continuous systematic exploration of plant foods and their phytochemicals is necessary for the development of new antiviral agents capable of saving lives and improving their well-being.Entities:
Keywords: antiviral agents; delivery technologies; phytochemicals; plant foods; replication; viruses
Year: 2021 PMID: 33921724 PMCID: PMC8073840 DOI: 10.3390/ph14040381
Source DB: PubMed Journal: Pharmaceuticals (Basel) ISSN: 1424-8247
Figure 1Various processes that a plant has to undergo for the establishment of an appropriate activity for a molecule.
Figure 2Flow chart of the research strategy adopted.
Figure 3General processes involved in the viral cell in order to replicate itself using host machinery.
Figure 4Overview on the main antiviral activities by different classes of drugs. (HSV—virus herpex simplex; HMCV—human cytomegalovirus; VZV—varicella zoster virus)
Different plants and phytochemicals exerting activity against numerous viruses.
| Plant | Family | Virus | Types of Extract | Antiviral Compounds | Ref. |
|---|---|---|---|---|---|
|
| Rutaceae | Human coxsackie viruses B1-B6, nuclear polyhedrosis virus | Hexane, ethyl acetate and methanol and aqueous | Marmelide, | [ |
| Amaryllidaceae | SARS-COV, | Ethanol | Quercetin, allicin, thiosulfinates | [ | |
| Amaryllidaceae | DENV, common cold virus, influenza virus A and B, HIV, HSV-1, HSV-2, Newcastle Disease Virus | Aqueous | Quercetin, allicin, thiosulfinates, ajoene | [ | |
|
| Liliaceae | HSV-1, HSV-2; | Gel | Unknown | [ |
|
| Moraceae | (SA-11) and human (HCR3) rotaviruses, HIV | - | Jacalin | [ |
|
| Zygophyllaceae | VSV T2 | Hexane, 80% methanol and water | Unknown | [ |
| Berberidaceae | Enterovirus 71, human cytomegalovirus (HCMV), CHIKV | - | Berbamine, berberine | [ | |
|
| Theaceae | HBV, HCV, HSV-1, HIV-1, caliciviruses | - | Catechins, quercetin, gallic acid, theaflavins, theaflavin-3,3′-digallate, theaflavin digallate, Epigallocathechin-3-gallate, (-)-epicatechin gallate | [ |
|
| Capparidaceae | HSV-2 | Methanol | Unknown | [ |
| Caricaceae | DENV | Aqueous | Unknown | [ | |
|
| Celastraceae | HIV-1 | - | Pentacyclic lupane-type triterpenoids | [ |
|
| Cistaceae | HIV-1, HIV-2 | - | ||
|
| Rutaceae | DENV; HIV-1, HSV types 1 and 2, influenza, and yellow fever. | - | Polysaccharides, polyphenols | [ |
|
| Zingiberaceae | HSV types 1 and 2 | - | Curcumin | [ |
|
| Ebenacee | Influenza virus H3N2, H5N3, HSV-1, vesicular stomatitis virus, Sendai virus, poliovirus, coxsachievirus, adenovirus, rotavirus, feline calicivirus, mouse norovirus, Newcastle disease virus | Aqueous | Licocoumarone, licoflavonol, | [ |
|
| Euforbiacee | HIV-1, HIV-2, SIV mac 251 | Aqueous | Flavonoids | [ |
|
| Euforbiacee | HSV type 1 | Methanol | Unknown | [ |
|
| Moraceae | HSV-1 | Latex | Unknown | [ |
|
| Fabaceae | HCV, HSV, CVB3, DHV, H5N1, Influenza virus, HRSV, | Aqueous, methanolic and ethanolic | Glycyrrhizin, 18 β-glycyrrhetinic | [ |
|
| Fabaceae | HCV; Rotavirus diarrhea | Methanol | Glycycoumarin, glycyrin, glycyrol, liquiritigenin, isoliquiritigenin, licochalcone A and glabridin | [ |
|
| Lamiaceae | HSV type 1 and 2 | - | Unknown | [ |
|
| Solanaceae | NDVs | - | Polysaccharides | [ |
|
| Lamiaceae | HSV-1, HSV-2 | Aqueous | Essential oils | [ |
|
| Lamiaceae | HSV type 1 | Methanol | Unknown | [ |
|
| Moringaceae | HSV type 1 | Aqueous | Unknown | [ |
|
| Moringaceae | HIV, HSV, HBV, EBV, FMDV and NDV. | - | Flavonoids and phenolic acids | [ |
|
| Myristicaceae | Human rotavirus | Unknown | [ | |
|
| Oleaceae | NDV | Aqueous | Unknown | [ |
|
| Araliaceae | RSV, influenza virus, HIV, HSV, hepatitis virus, enterovirus, coxsackievirus, norovirus, rotavirus rhinovirus, | - | Epigallocatechin gallate, theaflavin | [ |
|
| Araliaceae | Influenza A virus | Aqueous | Unknown | [ |
|
| Phyllanthaceae | HBV | - | Highly oxygenated norbisabolane | [ |
|
| Phyllanthaceae | Influenza A virus strain H3N2 | - | Highly oxygenated norbisabolane | [ |
|
| Piperaceae | HBV | - | Longumosides A and B, and two amide alkaloids | [ |
|
| Lamiaceae | HIV-1 | Aqueous | Unknown | [ |
|
| Myrtaceae | H1N1 viruses | Aqueous | Tannins and polyphenols | [ |
|
| Fagaceae | HSV-1 | Aqueous | Unknown | [ |
|
| Celastraceae | H1N1 viruses | Aqueous | Unknown | [ |
|
| Rosaceae | VSV, HSV-1 | Methanol/Water | Unknown | [ |
|
| Solanaceae | HCV | Methanol | Unknown | [ |
|
| Anacardiaceae | Human rotavirus, HSV type 1 | - | Hydrolysable tannins, O-glycosylated flavonoids, phenolic acids, and a carbohydrate | [ |
|
| Asteraceae | HCV | Methanol | Unknown | [ |
|
| Lamiaceae | HIV-1 | Methanol | Unknown | [ |
|
| Lamiaceae | HIV-1 | Aqueous | Unknown | [ |
|
| Lamiaceae | HIV-1 | Methanol | Unknown | [ |
|
| Lamiaceae | HIV-1 | Aqueous | Unknown | [ |
|
| Violaceae | HBV | - | Friedelolactones | [ |
|
| Labiate | HSV-1 | - | Rosmarinic acid | [ |
|
| Zingiberaceae | Chikungunya virus (CHIKV) | Aqueous | Unknown | [ |
Drug delivery systems employed for the treatment of viral infections.
| Phytochemicals or Extracts | Potential Antiviral Activity | Delivery System Strategy | Reference |
|---|---|---|---|
| Myricetin | HIV, RLV, influenza | Self-nanoemulsifying drug delivery systems SNEDDS, nanogel, mixed micelles, | [ |
| Apigenin | Influenza A, HCV, Enterovirus 71, FMDV, ASFV. | Solid dispersion, W/O/Wemulsion, O/W microemulsion, mixed micelles, phospholipid phytosome, self-microemulsifying drug delivery systems (SMEDDS) pellets | [ |
| Baicalin | DENV, RSV, HIV, Hepatitis B virus (HBV), influenza virus, NDV, enterovirus 71. | Liposome, mixed micelles, polymeric micelles, | [ |
| Catechins | HBV, HSV, EBV, Adenovirus, HIV, HCV, Influenza virus, DENV, JEV, TBEV Zika Virus (ZIKV), CHIKV, HTLV-1, Rotavirus, Enterovirus EV71, EBOV, PRRSV, VHSV, IHNV, SVCV, GCRV. | Microparticles, calcium pectinate gel particles, chitosan nanoparticles, Nanoparticles of Polylactic Acid–polyethylene Glycol, poly(lactic-co-glycolic acid) nanoparticles, gold nanoparticles, colloidal complexes, liposomes, nanoemulsions | [ |
| Hydroalcoholic extracts from Forsythiae fructus rich in Forsythoside A; Phillyrin; Calceolarioside; Rengynic acid | Influenza, RSV | Chito-oligosaccharides | [ |
| Extracts from Forsythiae fructus rich in 3,5-dicaffeoylquinic acid, 3,4-dicaffeoylquinic acid, neochlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isoforsythoside, forsythoside A, forsythoside B | Influenza, RSV, HIV, NDV | Chito-oligosaccharides | [ |
| Andrographolide | DENV, CHIKV, | Microspheres; nanosuspension and self-nanodispersion; nanoparticles, SMEDDS, | [ |
| Anthocyanin-rich extracts (from Mulberry) and purified compounds (i.e., delphinidin, cyanidin, and pelargonidin) | Influenza virus, HSV type 1 and 2, RV, Adenovirus 36, BT2, T4 and simian rotavirus SA-11, HAV, FCV-F9 and MNV-1, HCV, WNV, DENV, and ZIKV. | Micro/nanoencapsulation systems, nano/micro-gels, spray-drying and freeze-drying, electrohydrodynamic encapsulation, emulsification and liposomal encapsulation | [ |
| Curcumin | ZIKV, CHIKV, norovirus, Influenza, DENV type 2, | Nanoparticles, solid dispersion, SNEDDS, SMEDDS, lipid carrier, copolymeric and mixed micelles, exosomes | [ |
| Water extract from Panax ginseng root and punicalagin | HSV types 1 and 2 | Hydroxypropyl methylcellulose (HPMC) hydrogel | [ |
| Water extract from Panax ginseng root and punicalagin | Influenza A virus (strain A/PR/8) | Ultra-sonication-assisted silver nanoparticles | [ |
| Hydroalcoholic extract from Elderberry and Eucalyptus | Influenza virus | Oil-in-water (o/w) and water-in-oil (w/o) emulsions | [ |
| Hydroalcoholic extract from Elderberry and Eucalyptus | Common cold | Encapsulation | [ |
| Coumestrol | HSV types 1 and 2 | Lipid nanoemulsion based on dioleylphosphocholine | [ |
| Quercetin | JEV, influenza A, EBV, MAYV, RV, HCV | Nanocrystal, nanoparticles phytosome, nanoliposome, mixed micelles, SNEDDS, nanocarrier, nanoemulsion, nanosuspension | [ |
| Naringenin | DENV, HCV | SNEDDS, solid dispersion, nanoparticles, liposome, nanosuspension, cyclodextrin complex | [ |
| Resveratrol | HIV/AIDS | Polymeric nanoparticles, solid-liquid nanoparticles, self-emulsifying methods, nanosponges, liposomes, emulsion-liposome blends, lipid-core nanocapsules, active lipospheres | [ |
| Silibinin | Hepatitis C virus infection | Encapsulation based on phytoliposomes | [ |
Figure 5Major groups of phytochemical classes presenting antiviral activities.